Abstract
Objectives
Recurrent aphthous stomatitis (RAS) is a common ulcerative disease of the oral mucosa. Methylenetetrahydrofolate reductase (MTHFR) gene variants are associated with thrombophilia and vasculopathy that may result in oral ulceration. Oral ulcers are also the most common feature of Behcet’s disease (BD). Association of MTHFR gene C677T mutation with BD has been reported in different populations. The aim of the present study was to investigate the possible association between MTHFR gene C677T mutation and RAS and evaluate if there was an association with clinical features in a relatively large cohort of Turkish patients.
Materials and methods
The study included 188 patients affected by RAS and 200 healthy controls. Genomic DNA was isolated and genotyped using polymerase chain reaction (PCR)-based restriction fragment length polymorphism (RFLP) assay for the MTHFR gene C677T mutation.
Results
The genotype and allele frequencies of C677T mutation showed statistically significant differences between RAS patients and controls (p = 0.002 and p = 0.0004, respectively). After stratifying RAS patients according to clinical characteristics of oral ulcers, a significant association was observed between C677T mutation and number of oral ulcers of RAS patients (p = 0.006).
Conclusions
As a result, a high association between MTHFR gene C677T mutation and RAS was observed in the present study. Also number of oral ulcers was found to be associated with MTHFR C677T mutation in RAS patients.
Clinical Relevance
If our observation can be substantiated with further studies, evaluation for MTHFR mutations and perhaps folate supplementation may become necessary in selected patients.
Similar content being viewed by others
References
Porter SR, Scully C, Pedersen A (1998) Recurrent aphthous stomatitis. Crit Rev Oral Biol Med 9:306–321
Scully C, Porter S (2008) Oral mucosal disease: recurrent aphthous stomatitis. Br J Oral Maxillofac Surg 46:198–206
Natah SS, Konttinen YT, Enattah NS, Ashammakhi N, Sharkey KA, Häyrinen-Immonen R (2004) Recurrent aphthous ulcers today: a review of the growing knowledge. Int J Oral Maxillofac Surg 33:221–234
Bang D, Yoon KH, Chung HG, Choi EH, Lee ES, Lee S (1997) Epidemiological and clinical features of Behcet’s disease in Korea. Yonsei Med J 38:428–436
Koubaa N, Hammami S, Nakbi A, Ben Hamda K, Mahjoub S, Kosaka T, Hammami M (2008) Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Behçet's disease patients. Clin Chem Lab Med 46(2):187–192
Karakus N, Yigit S, Kalkan G, Rustemoglu A, Inanir A, Gul U, Pancar GS, Akkanet S, Ates O (2012) Association between the methylene tetrahydrofolate reductase gene C677T mutation and colchicine unresponsiveness in Behcet's disease. Mol Vis 18:1696–1700
Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M (2003) Effect of methylenetetrahydrofolate reductase 677CRT polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294–299
Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111–113
Hankey GJ, Eikelboom JW (1999) Homocysteine and vascular disease. Lancet 354(9176):407–413
Kang SS, Zhou J, Wong PW, Kowalisyn J, Strokosch G (1988) Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43:414–421
Rosendaal FR (1997) Risk factors for venous thrombosis: prevalence, risk, and interaction. Sem Hematol 34:171–177
Seshadri N, Homocysteine RK (2000) B vitamins and coronary artery disease. Med Clin North Am 84:215–217
Ship JA, Chavez EM, Doerr PA, Henson BS, Sarmadi M (2000) Recurrent aphthous stomatitis. Quintessence Int 31:95–112
Keijzer MB, Heijer M, Blom HJ, Bos GM, Willems HP, Gerrits WB, Rosendaal FR (2002) Interaction between hyperhomocysteinemia, mutated methylenetetrahydrofolate reductase (MTHFR) and inherited thrombophilic factors in recurrent venous thrombosis. Thromb Haemost 88:723–728
Li XM, Wei YF, Hao YB, Hao YB, He LS, Li JD, Mei B, Wang SY, Wang C, Wang JX, Zhu JZ, Liang JQ (2002) Hyperhomocysteinemia and MTHFR mutation in Budd–Chiari syndrome. Am J Hematol 71:11–14
Ehrenforth S, Nemes L, Mannhalter C, Rosendaal FR, Koder S, Zoghlami-Rintelen C, Scharrer I, Pabinger I (2004) Impact of environmental and hereditary risk factors on the clinical manifestation of thrombophilia in homozygous carriers of factor V: G1691A. J Thromb Haemost 2:430–436
Alpsoy E, Donmez L, Bacanli A, Apaydin C, Butun B (2003) Review of the chronology of clinical manifestations in 60 patients with Behcet’s disease. Dermatology 207:354–356
Pipitone N, Boiardi L, Olivieri I, Cantini F, Salvi F, Malatesta R, La Corte R, Triolo G, Ferrante A, Filippini D, Paolazzi G, Sarzi-Puttini P, Restuccia G, Salvarani C (2004) Clinical manifestations of Behcet’s disease in 137 Italian patients: results of a multicenter study. Clin Exp Rheumatol 22(6 suppl 36):46–51
Wilcox GM, Mattia AR (2006) Celiac sprue, hyperhomocysteinemia, and MTHFR gene variants. J Clin Gastroenterol 40(7):596–601
Dönmez G, Dönmez AD, Ozçakar L (2009) Do MTHFR mutations kick in during familial Mediterranean fever attacks? Acta Reumatol Port 34(3):561–562
Oussalah A, Guéant JL, Peyrin-Biroulet L (2011) Meta-analysis: hyperhomocysteinaemia in inflammatory bowel diseases. Aliment Pharmacol Ther 34(10):1173–1184
New D, Eaton P, Knable A, Callen JP (2011) The use of B vitamins for cutaneous ulcerations mimicking pyoderma gangrenosum in patients with MTHFR polymorphism. Arch Dermatol 147(4):450–453
Stanger O, Herrmann W, Pietrzik K, Fowler B, Geisel J, Dierkes J, Weger M (2003) DACH-LIGA Homocystein e.V. DACH-LIGA Homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin Chem Lab Med 41:1392–1403
Fernandez-Banares F, Abad-Lacruz A, Xiol X, Gine JJ, Dolz C, Cabre E, Esteve M, Gonzalez-Huix F, Gassull MA (1989) Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 84:744–748
Saibeni S, Cattaneo M, Vecchi M, Zighetti ML, Lecchi A, Lombardi R, Meucci G, Spina L, de Franchis R (2003) Low vitamin B(6) plasma levels, a risk factor for thrombosis, in inflammatory bowel disease: role of inflammation and correlation with acute phase reactants. Am J Gastroenterol 98:112–117
Jacques PF, Bostom AG, Williams RR, Ellison RC, Eckfeldt JH, Rosenberg IH, Selhub J, Rozen R (1996) Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93:7–9
Conflicts of interest
The authors declare that they have no conflicts of interests.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Kalkan, G., Karakus, N. & Yigit, S. Association of MTHFR gene C677T mutation with recurrent aphthous stomatitis and number of oral ulcers. Clin Oral Invest 18, 437–441 (2014). https://doi.org/10.1007/s00784-013-0997-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00784-013-0997-0